References
- Splinting for the prevention and correction of contractures in adults with neurological dysfunction, College of Occupational Therapists and Association of Chartered Physiotherapists in Neurology, 2015
- Costing statement: Pressure ulcers. Implementing the NICE guideline on pressure ulcers (CG179). NICE April 2014
- Lundstrom E et al. Four-Fold Increase in Direct Costs of Stroke Survivors With Spasticity Compared With Stroke Survivors Without Spasticity: The First Year After the Event. Stroke. 2010;41:319-324
- Coleman CI et al. Impact of Mobility Impairment on Indirect Costs and Health-Related Quality of Life in Multiple Sclerosis. PLoS One. 2013; 8(1): e54756.
- Spasticity in adults: management using botulinum toxin. National guidelines.Royal College of Physicians,Working Party, 2009
- Ward AB, Roberts G, Warner J, Gillard S (2005) Cost-effectiveness of Botulinum Toxin type A in the treatment of post-stroke spasticity. Journal of Rehabilitation Medicine 37(4):252–7.
- Wallesch C-W, Meas E, Lecomte P et al (1997) Cost-effectiveness of Botulinum Toxin type A injection in patients with spasticity following stroke: a German perspective. European Journal of Neurology 4(2):S53–S57.
- National Service Framework for Older People. London, Department of Health, 2001.
- Wissel J et al. (2009) European Consensus Table on the Use of the Botulinum Toxin Type A in Adult Spasticity. J Rehab Med. 41: 13–25
- Rosales RL, Kong KH, Goh KJ, Kumthornthip W, Tong Mok VC, Los Santos MMD, Chua KSG, Abdullah SJbF, Zakine B, Maisonobe P, Magis A, Wong KSL. (2012) Botulinum Toxin Injection for Hypertonicity of the Upper Extremity Within 12 Weeks After Stroke: A Randomized Controlled Trial. Neurorehabilitation and Neural Repair. 26(7) 812-821.
Guidelines
Spasticity in adults: management using Botulinum Toxin; National guidelines RCP 2009
Spasticity in adults: management using Botulinum Toxin; National guidelines RCP 2018 (due for
publication March 2018)
RCP National clinical guideline for stroke, RCP 2016
Spasticity in under 19s: management NICE Clinical Guidance (CG145) 2012
Transforming Community Services, Demonstrating and Measuring Achievement: Community Indicators
for Quality Improvement: DH 2011
Multiple sclerosis in adults: management NICE Clinical guideline (CG186) 2014
Stroke Rehabilitation in Adults NICE Clinical guideline (CG162), 2013
Neuro numbers: a brief review of the numbers of people in the UK with neurological conditions,
London The Neurological Alliance, 2003